Literature DB >> 25498090

Incidence and risk factors of deep vein thrombosis after liver transplantation.

A Annamalai1, I Kim2, V Sundaram2, A Klein2.   

Abstract

BACKGROUND: Deep venous thrombosis (DVT) occurs in 0.1% of persons per year, affecting 15%-40% of general surgical procedures without prophylaxis. Thromboembolic prophylaxis is not commonly used after orthotopic liver transplantation (LT) owing to the risks of bleeding and coagulopathy. Cirrhosis and the association with the coagulation cascade, before and after transplantation, are not well understood. The purpose of this study was to determine the incidence of DVT and its risk factors after LT.
METHODS: We retrospectively reviewed LTs performed at our center from 2005 to 2012. We identified patients with Doppler examinations showing DVT after LT, platelet count, and international normalized ratio (INR) at time of DVT, associated symptoms, DVT prophylaxis, and perioperative risk factors. We determined the incidence of DVT, the odds ratio of each preoperative risk factor, the difference in platelet count and INR between those with and without a DVT, and the weighted risk of each factor in the development of DVT with the use of logistic regression modeling.
RESULTS: Of 314 patients, the incidence of DVT was 8.6% (27/314). Between those with and without DVT there was no significant difference in age, sex, platelet count, INR, infection, hepatocellular cancer, use of venous bypass, and prior surgery. There was a significant difference in mobility, 67% vs 20% (P < .0001), and the use of factor VII, 11% vs 2% (P < .05). The estimated risk for of developing DVT for patients with neither of these factors was 4%; with factor VII the risk rose to 17%; with mobility difficulty the risk rose to 23%; and with both the risk was 62%. In our entire population, there were no cases of pulmonary embolism.
CONCLUSIONS: The risk of developing a DVT after LT is ≥9% even with mechanical DVT prophylaxis. Consideration should be given to using both mechanical and chemical prophylaxis after LT.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25498090     DOI: 10.1016/j.transproceed.2014.09.113

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

Review 1.  Deep vein thrombosis during long-term surveillance of patients with liver transplantation.

Authors:  Alice Balaceanu
Journal:  Ir J Med Sci       Date:  2019-03-08       Impact factor: 1.568

Review 2.  Perioperative thrombotic complications in liver transplantation.

Authors:  Paolo Feltracco; Stefania Barbieri; Umberto Cillo; Giacomo Zanus; Marco Senzolo; Carlo Ori
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

3.  Anticoagulant therapy with fondaparinux in a liver transplant patient with thrombosis and liver fibrosis: a case report.

Authors:  Arturo Cafolla; Giuseppe Gentile
Journal:  Clin Case Rep       Date:  2017-02-09

4.  Deep Vein Thrombosis and Pulmonary Embolism in Liver Transplant Patients: Risks and Prevention.

Authors:  James Yip; David A Bruno; Charlotte Burmeister; Marwan Kazimi; Atsushi Yoshida; Marwan S Abouljoud; Gabriel T Schnickel
Journal:  Transplant Direct       Date:  2016-03-01

Review 5.  Perioperative thromboprophylaxis in liver transplant patients.

Authors:  Lesley De Pietri; Roberto Montalti; Daniele Nicolini; Roberto Ivan Troisi; Federico Moccheggiani; Marco Vivarelli
Journal:  World J Gastroenterol       Date:  2018-07-21       Impact factor: 5.742

6.  Efficacy of pro- and anticoagulant strategies in plasma of patients undergoing hepatobiliary surgery.

Authors:  Sarah Bos; Bente van den Boom; Tsai-Wing Ow; Andreas Prachalias; Jelle Adelmeijer; Anju Phoolchund; Fraser Dunsire; Zoka Milan; Mark Roest; Nigel Heaton; William Bernal; Ton Lisman
Journal:  J Thromb Haemost       Date:  2020-09-10       Impact factor: 5.824

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.